Bioatla
Price & Volume
Stats
See more52W Range | $0.24-$1.43 |
Market Cap | $21.1M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 31.6% |
Gross Profit (12 Mos) | -$46.7M |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • 12 days ago
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Yahoo Finance • last month
After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance
Yahoo Finance • last month
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb
Yahoo Finance • 2 months ago
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing
About
CEO | Dr. Jay M. Short Ph.D. |
CFO | Mr. Richard A. Waldron |
Address | 11085 Torreyana Road, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
